Seth and Nick discuss how technology is used to develop regenerative medicine for conditions such as Parkinson’s disease and Alzheimer’s disease.
Seth Ettenberg is CEO and President of BlueRock Therapeutics, a wholly owned subsidiary of Bayer. He’s a biotech entrepreneur, on the cutting edge of something called regenerative medicine.
Leave A Comment